| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |